A core epitope targeting antibody of SARS-CoV-2

Protein Cell. 2022 Oct 26;14(1):74-78. doi: 10.1093/procel/pwac042. eCollection 2023 Jan.

Simeng Zhao¹, Fengjiang Liu^{2

3}, Shizhen Qiu⁴, Qiaoshuai Lan⁵, Yiran Wu¹, Wei Xu⁵, Junzi Ke^{1

4}, Jie Yang^{1

4}, Xiaoyan Liu¹, Kun Wang⁴, Hangtian Guo², Shuai Xia⁵, Fangfang Zhang¹, Jiabei Wang⁶, Xiaowen Hu⁷, Lu Lu⁵, Shibo Jiang⁵, Suwen Zhao^{1

4}, Lianxin Liu⁸, Youhua Xie⁵, Xiuna Yang², Haopeng Wang⁴, Guisheng Zhong^{1

4}

¹ iHuman Institute, ShanghaiTech University, Shanghai 201210, China.
² Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University, Shanghai 201210, China.
³ Innovative Center for Pathogen Research, Guangzhou Laboratory, Guangzhou 510005, China.
⁴ School of Life Science and Technology, ShanghaiTech University, Shanghai 201210, China.
⁵ Key Laboratory of Medical Molecular Virology (MOE/NHC/CAMS), School of Basic Medical Sciences and Biosafety Level 3 Laboratory, Fudan University, Shanghai 200032, China.
⁶ Department of Hepatobiliary Surgery, Anhui Province Key Laboratory of Hepatopancreatobiliary Surgery, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, The University of Science and Technology of China, Hefei 230001, China.
⁷ Department of Pulmonary and Critical Care Medicine, Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, The University of Science and Technology of China, Hefei 230026, China.
⁸ Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, The University of Sciences and Technology of China, Hefei 230001, China.

No abstract available

Publication types